BD Alaris Infusion Central
Advisory ansehen veröffentlicht 2023-02-16
This updated advisory is a follow-up to the original advisory titled ICSMA-23-047-01 BD Alaris Infusion Central that was published February 16, 2023, to the ICS webpage on www.cisa.gov/uscert.
01
beschreibt (1)
Zugehörige CVEs.
| ID | Schweregrad | ausnutzbar | ||
|---|---|---|---|---|
| CVE-2022-47376US | high7.3 | — | ||
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although s… | ||||
02
Referenzen
Externe Belege — Patches, Meldungen, Analysen.
- Recommended Practicesexternal
- ICS Advisory ICSMA-23-047-01 JSONself
- Recommended Practicesexternal
- ICS Advisory ICSMA-23-047-01 Web Versionself
- Recommended Practicesexternal
- Recommended Practicesexternal
03
Behebungen (2)
- MitigationAlaris Infusion Central software
Change passwords periodically per best security practice.
- BehobenAlaris Infusion Central software
BD is directly reaching out to the small group of customers who may be impacted by this vulnerability to initiate remediation.
scry
Advisories wie diese benennen die exponierten Produkte, die Angreifer auf Ihrer Angriffsfläche ins Visier nehmen. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.
Kostenloser Scan